Sponsor - Emmes Corporation (Closed to Enrollment)
Study: MacTel NHOR
A Natural History Observation and Registry Study of Macular Telangiectasia Type 2
Sponsor - Neurotech Pharmaceuticals Inc. (Closed to Enrollment)
Study: NTMT-03-B
A Phase 3 Multicenter, Randomized, Sham-Controlled Study to Determine the Safety and Efficacy of Renexus in Macular Telangiectasia Type 2